Related Experiment Video

Updated: Jul 19, 2026

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
06:05

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins

Published on: September 30, 2014

The immunoglobulin A1 proteinase from Streptococcus pneumoniae is inhibited by tetracycline compounds

Stephen G Walker1, Oana I Carnu, Gülay Tüter

  • 1Department of Oral Biology and Pathology, School of Dental Medicine, State University of New York at Stony Brook, NY 11794-8702, USA. stephen.walker@stonybrook.edu

FEMS Immunology and Medical Microbiology
|September 26, 2006
PubMed

Insights

Tetracyclines like doxycycline inhibit a key Streptococcus pneumoniae enzyme that aids bacterial colonization. This discovery offers potential new strategies against pneumococcal infections by targeting this zinc-dependent proteinase.

Area of Science:

  • Microbiology
  • Biochemistry
  • Immunology

Background:

  • Streptococcus pneumoniae utilizes a zinc-dependent proteinase to cleave human immunoglobulin A1 (IgA1).
  • This IgA1 cleavage is a proposed virulence factor, aiding pneumococcal colonization in the nasopharynx by evading immune defenses.
  • No effective, biologically compatible inhibitors for this metalloproteinase have been identified.

Purpose of the Study:

  • To investigate potential inhibitors of the Streptococcus pneumoniae zinc-dependent proteinase.
  • To explore the therapeutic implications of inhibiting this metalloproteinase for treating pneumococcal infections.

Main Methods:

  • In vitro enzymatic assays were performed to assess inhibition.
  • Doxycycline and a chemically modified tetracycline were tested against the proteinase.

Main Results:

  • Doxycycline was found to inhibit the enzyme.
  • A chemically modified tetracycline also demonstrated inhibitory activity.
  • Both inhibitors were effective at low micromolar concentrations in vitro.

Conclusions:

  • Doxycycline and a modified tetracycline show potential as inhibitors of the Streptococcus pneumoniae IgA1-cleaving proteinase.
  • These findings suggest a novel therapeutic approach targeting pneumococcal virulence mechanisms.
  • Further research may lead to new treatments for infections caused by Streptococcus pneumoniae.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...